Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NY: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 3 4 5 6 7 Next >
Par Announces Completion Of Acquisition By TPG
September 28, 2012
from PR Newswire
ADT, Pentair Set to Join the S&P 500; Lexmark, DeVry to Join the S&P MidCap 400 and MarketAxess to Join the S&P SmallCap 600
September 24, 2012
from PR Newswire
Par Pharmaceutical Companies Announces The Expiration Of The "Go Shop" Period, Receipt Of Early Termination Of HSR Waiting Period And Special Meeting Date
August 27, 2012
from PR Newswire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Par Pharmaceutical Companies, Inc.
August 15, 2012
from Business Wire News Releases
Par Pharmaceutical Companies Reports Second Quarter 2012 Results
August 02, 2012
Reports Q2 2012 Adjusted Cash EPS of $1.62; GAAP $1.38 per Share Read More
from PR Newswire
Ryan & Maniskas, LLP Announces Investigation of Par Pharmaceutical Companies Inc.
July 20, 2012
from Business Wire News Releases
Law Offices of Todd M. Garber Announces Investigation of Par Pharmaceuticals Cos.
July 19, 2012
from Business Wire News Releases
Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Par Pharmaceutical Companies, Inc.
July 19, 2012
from PR Newswire
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Par Pharmaceutical Companies Inc. in Connection with the Sale of the Company t
July 18, 2012
from Business Wire News Releases
Law Office of Brodsky & Smith, LLC Announces Investigation of Par Pharmaceuticals Companies, Inc.
July 18, 2012
from Business Wire News Releases
Law Firm Brower Piven Announces Investigation in Connection With Par Pharmaceutical Companies, Inc. Buyout
July 18, 2012
from Business Wire News Releases
Law Office of Brodsky & Smith, LLC Announces Investigation of Par Pharmaceuticals Companies, Inc.
July 17, 2012
from PR Newswire
The Lin Law Firm Investigates Potential Breaches of Fiduciary Duties In Connection With Proposed Acquisition of Par Pharmaceutical Companies Inc.
July 17, 2012
from PR Newswire
Law Offices of Howard G. Smith Announces Investigation of Par Pharmaceuticals Cos.
July 17, 2012
from Business Wire News Releases
Robbins Umeda LLP Announces an Investigation of Par Pharmaceutical Companies, Inc.
July 17, 2012
from Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Par Pharmaceutical Companies Inc. in Connection with the Sale of the Company t
July 17, 2012
from PR Newswire
Ryan & Maniskas, LLP Announces Investigation of Par Pharmaceutical Companies Inc.
July 17, 2012
from Business Wire News Releases
Par Pharmaceutical Shareholder Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Sale of Par Pharmaceutical Companies, Inc. to TPG
July 17, 2012
from Business Wire News Releases
Top Stock Alerts for Day Traders: Human Genome Sciences, Hewlett-Packard, Visa, Par Pharmaceutical, Nokia, and SandRidge Energy
July 17, 2012
from PR Newswire
Faruqi & Faruqi, LLP is Seeking More Cash for the Shareholders of Par Pharmaceutical Companies, Inc. (PRX)
July 16, 2012
from Business Wire News Releases
The Law Firm of Weiss & Lurie Investigates Par Pharmaceutical Companies, Inc.
July 16, 2012
from Business Wire News Releases
Par Pharmaceuticals Cos. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Goldberg LLP
July 16, 2012
from Business Wire News Releases
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Par Pharmaceutical Companies Inc. in Connection with the Sale of the Company t
July 16, 2012
from Business Wire News Releases
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Par Pharmaceutical Companies
July 16, 2012
from Business Wire News Releases
Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
July 16, 2012
from PR Newswire
Par Pharmaceutical Companies Enters Into Definitive Agreement To Be Acquired By TPG
July 16, 2012
Par Shareholders to Receive $50.00 per Share in Cash; Fully Diluted Equity Value of $1.9 Billion Read More
from PR Newswire
Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
July 13, 2012
Par Anticipates Shipping Generic Trandate® in August Read More
from PR Newswire
Par Pharmaceutical Companies to Report Second Quarter 2012 Results on August 2, 2012
July 09, 2012
from PR Newswire
Par Pharmaceutical Companies Reports First Quarter 2012 Results
May 08, 2012
Reports Q1 2012 Adjusted Cash EPS of $0.80; GAAP Loss of $0.79 per Share Read More
from PR Newswire
Par Pharmaceutical Acquires Rights to Market and Distribute Generic Dexilant® in the U.S.
April 19, 2012
Potential for 180 Day Marketing Exclusivity Read More
from PR Newswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here